D. E. I. Pyott - Jun 13, 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Director
Signature: /s/ Mike Ouimette, attorney-in-fact
Stock symbol: PLRX
Transactions as of: Jun 13, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/17/2024, 08:16 PM
Previous filing: May 23, 2024
Next filing: Jun 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Common Stock (Right to Buy)	Award	$0	+26.8K		$0.00	26.8K	Jun 13, 2024	Common Stock	26.8K	$13.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 13th, 2024 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 13, 2024 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.

Content

25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 13th, 2024 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 13, 2024 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.